Propel Bio Management, LLC Diversified Active

Location: Los Angeles, CA

CIK: 0001969764 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 13, 2024

Total Value: $172M (100.0% shares, 0.0% debt)

Holdings (21)

— APPLIED THERAPEUTICS INC 32.4%

Value $55.83M Shares 6,567,858 Est. Cost $3.83 Unrealized —

PAGP PLAINS GP HOLDINGS LP-CL 13.7%

Value $23.54M Shares 1,272,360 Est. Cost $18.82 Unrealized —

PHAT PHATHOM PHARMACEUTICALS I 9.1%

Value $15.73M Shares 869,927 Est. Cost $8.56 Unrealized +63.4%

ACHV ACHIEVE LIFE SCIENCES INC 6.7%

Value $11.63M Shares 2,453,092 Est. Cost $4.44 Unrealized +2.9%

TCRX TSCAN THERAPEUTICS INC 6.0%

Value $10.39M Shares 2,087,139 Est. Cost $4.58 Unrealized +31.8%

— AKERO THERAPEUTICS INC 5.7%

Value $9.862M Shares 343,729 Est. Cost $24.86 Unrealized —

MDGL MADRIGAL PHARMACEUTICALS 5.3%

Value $9.132M Shares 43,032 Est. Cost $193.31 Unrealized +32.3%

RNAM AVIDITY BIOSCIENCES INC 4.8%

Value $8.199M Shares 178,500 Est. Cost $6.68 Unrealized +549.2%

ARDX ARDELYX INC 4.3%

Value $7.379M Shares 1,070,947 Est. Cost $5.46 Unrealized +8.0%

TSAT TELESAT CORP 2.8%

Value $4.817M Shares 365,781 Est. Cost $10.56 Unrealized -9.6%

ABEO ABEONA THERAPEUTICS INC 2.3%

Value $3.944M Shares 624,022 Est. Cost $5.10 Unrealized +2.3%

KYMR KYMERA THERAPEUTICS INC 1.5%

Value $2.667M Shares 56,359 Est. Cost $17.88 Unrealized +146.9%

SNDX SYNDAX PHARMACEUTICALS IN 1.5%

Value $2.565M Shares 133,259 Est. Cost $21.69 Unrealized -4.7%

KURA KURA ONCOLOGY INC 1.5%

Value $2.54M Shares 130,000 Est. Cost $9.83 Unrealized +106.1%

ZVRA ZEVRA THERAPEUTICS INC 0.7%

Value $1.248M Shares 179,874 Est. Cost $6.78 Unrealized 0.0%

— EIGER BIOPHARMACEUTICALS 0.7%

Value $1.244M Shares 146,381 Est. Cost $5.00 Unrealized —

— ATHIRA PHARMA INC 0.4%

Value $666K Shares 1,492,792 Est. Cost $2.43 Unrealized —

CMPS COMPASS PATHWAYS LTD 0.3%

Value $504K Shares 80,000 Est. Cost $6.30 Unrealized —

— VERRICA PHARMACEUTICALS I 0.3%

Value $500K Shares 344,937 Est. Cost $7.29 Unrealized —

MATPF MAAT PHARMA SACA 0.0%

Value $17,786 Shares 2,397 Est. Cost $7.42 Unrealized —

— CHINOOK THERAPEUTICS 0.0%

Value $9,750 Shares 79,357 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	APPLIED THERAPEUTICS INC	6,567,858	$55.83M	32.4%	$3.83	—	COMM	03828A101
PAGP	PLAINS GP HOLDINGS LP-CL	1,272,360	$23.54M	13.7%	$18.82	—	COMM	72651A207
PHAT	PHATHOM PHARMACEUTICALS I	869,927	$15.73M	9.1%	$8.56	+63.4%	COMM	71722W107
ACHV	ACHIEVE LIFE SCIENCES INC	2,453,092	$11.63M	6.7%	$4.44	+2.9%	COMM	004468500
TCRX	TSCAN THERAPEUTICS INC	2,087,139	$10.39M	6.0%	$4.58	+31.8%	COMM	89854M101
—	AKERO THERAPEUTICS INC	343,729	$9.862M	5.7%	$24.86	—	COMM	00973Y108
MDGL	MADRIGAL PHARMACEUTICALS	43,032	$9.132M	5.3%	$193.31	+32.3%	COMM	558868105
RNAM	AVIDITY BIOSCIENCES INC	178,500	$8.199M	4.8%	$6.68	+549.2%	COMM	05370A108
ARDX	ARDELYX INC	1,070,947	$7.379M	4.3%	$5.46	+8.0%	COMM	039697107
TSAT	TELESAT CORP	365,781	$4.817M	2.8%	$10.56	-9.6%	COMM	879512309
ABEO	ABEONA THERAPEUTICS INC	624,022	$3.944M	2.3%	$5.10	+2.3%	COMM	00289Y206
KYMR	KYMERA THERAPEUTICS INC	56,359	$2.667M	1.5%	$17.88	+146.9%	COMM	501575104
SNDX	SYNDAX PHARMACEUTICALS IN	133,259	$2.565M	1.5%	$21.69	-4.7%	COMM	87164F105
KURA	KURA ONCOLOGY INC	130,000	$2.54M	1.5%	$9.83	+106.1%	COMM	50127T109
ZVRA	ZEVRA THERAPEUTICS INC	179,874	$1.248M	0.7%	$6.78	0.0%	COMM	488445206
—	EIGER BIOPHARMACEUTICALS	146,381	$1.244M	0.7%	$5.00	—	COMM	28249U204
—	ATHIRA PHARMA INC	1,492,792	$666K	0.4%	$2.43	—	COMM	04746L104
CMPS	COMPASS PATHWAYS LTD	80,000	$504K	0.3%	$6.30	—	COMM	20451W101
—	VERRICA PHARMACEUTICALS I	344,937	$500K	0.3%	$7.29	—	COMM	92511W108
MATPF	MAAT PHARMA SACA	2,397	$17,786	0.0%	$7.42	—	COMM	F5888J116
—	CHINOOK THERAPEUTICS	79,357	$9,750	0.0%	—	—	COMM	169CVR016